XCHG Ltd ADR Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $25.1M-40.5% YoYTTM through 31 Dec 2025
Net Income -$32.5MTTM through 31 Dec 2025
Free Cash Flow -$7.5MTTM through 31 Dec 2025
Margins
| Current | |
|---|---|
| Gross Margin | 46.2% |
| EBITDA Margin | -128.8% |
| Operating Margin | -130.0% |
| Net Margin | -129.5% |
Returns
-137.2%ROE
-65.1%ROA
Balance Sheet Health
Debt / Equity0.46x
Current Ratio1.58x
Net Debt-$3.2Mnet cash position
Cash & Equivalents$11.4M
Quality Metrics
Altman Z-Score-4.04
Piotroski F-Score2 / 9
FCF Margin-30.0%
Multi-Year Trend
RevenueFY2025: $25.1M
Diluted EPSFY2025: $-0.01
Dividend
No dividend
Capital Allocation
R&D Spend$7.1M
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.